Unit dosage composition comprising midazolam

EP4687838A2Pending Publication Date: 2026-02-11B BRAUN MELSUNGEN AG

0 Cites 0 Cited by

Patent Information

Application Number: EP2024719294
Authority / Receiving Office: EP · EP
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2023-04-06
Filing Date: 2024-04-05
Publication Date: 2026-02-11

Application Information

Patent Timeline

06 Apr 2023

Priority

05 Apr 2024

Application

EP2024719294

11 Feb 2026

Publication

EP4687838A2

IPC: A61K9/00; A61K31/5517; A61K47/10; A61K47/32; A61K47/38; A61K47/40; A61P25/08; A61P25/20; A61P25/22

CPC: A61K31/5517; A61K9/0056; A61K47/40; A61K47/38; A61K47/32; A61K47/10; A61P25/08; A61K9/006

Inventors: JANAS, CHRISTINE; PORREDON GUARCH, CONSTANCA

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure IB2024053351_10102024_PF_FP_ABST

Patent Text Reader

Abstract

The present invention relates to a unit dosage composition comprising midazolam or a pharmaceutically acceptable salt thereof, a cyclodextrin, and at least one matrix material, as well as to the use of said unit dosage composition in medicine and therapy, in particular in the treatment of febrile seizure, epileptic seizure, such as status epilepticus, fear, such as preoperative anxiolysis to reduce fear, and / or agitation, such as agitation prior to surgery.

Need to check novelty before this filing date? Find Prior Art